On 13 May 2008 HemCon Medical Technologies Inc. completed the acquisition of Alltracel Pharmaceuticals Plc. 

Alltracel, The  Healthcare Innovation Group, is focused on taking proprietary technology from research right through to commercialisation in the global healthcare market. Alltracel Pharmaceuticals Plc., ("Alltracel") was founded in 1996.

With European headquarters in Dublin, Ireland; Alltracel has commercial offices in London, England and Königswinter, Germany; an R&D subsidiary in the Czech Republic and manufacturing facilities in Shenzhen, China. Alltracel also has a wide network of research, development and manufacturing partners in Europe, Asia and North America. Alltracel operates via two main divisions Alltracel Healthcare Group and Alltracel Healthcare Technologies.

Alltracel Healthcare Group is focused on the commercialisation effort behind proven innovative technologies and services. Alltracel Healthcare Holdings has a range of stake holdings, joint ventures and wholly owned business units operating in a variety of healthcare categories including Wound Care, Oral Care, Cardiovascular Health and Cosmeceuticals.

Alltracel Healthcare Technologies specialises in innovation, research and development and the deployment of proprietary breakthrough technology.
Alltracel Healthcare Technologies has established a substantial intellectual property portfolio with international patents in a number of Healthcare application areas.